PEGylation of Protein-based MRI Contrast Agents Improves Relaxivities and Biocompatibilities

Magnetic resonance imaging (MRI) has emerged as a leading diagnostic technique in clinical and preclinical settings. However, the application of MRI to assess specific disease markers for diagnosis and monitoring drug effect has been severely hampered by the lack of desired contrast agents with high...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Li, Shunyi, Jiang, Jie, Zou, Jin, Qiao, Jingjuan, Xue, Shenghui, Wei, Lixia, Long, Robert, Wang, Liya, Castiblanco, Adriana, White, Natalie, Ngo, Jen, Mao, Hui, Liu, Zhi-Ren, Yang, Jenny J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3273044/
https://ncbi.nlm.nih.gov/pubmed/22178673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jinorgbio.2011.11.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak